Allspring Global Investments Holdings LLC Increases Stock Position in Addus HomeCare Corporation $ADUS

Allspring Global Investments Holdings LLC grew its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUSFree Report) by 8.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 92,931 shares of the company’s stock after buying an additional 7,522 shares during the period. Allspring Global Investments Holdings LLC owned 0.50% of Addus HomeCare worth $8,722,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ADUS. Fifth Third Bancorp lifted its position in Addus HomeCare by 5,612.5% during the 1st quarter. Fifth Third Bancorp now owns 8,683 shares of the company’s stock valued at $813,000 after acquiring an additional 8,531 shares during the period. Hsbc Holdings PLC grew its stake in shares of Addus HomeCare by 79.6% in the 1st quarter. Hsbc Holdings PLC now owns 14,113 shares of the company’s stock worth $1,333,000 after buying an additional 6,253 shares during the last quarter. Azzad Asset Management Inc. ADV grew its stake in shares of Addus HomeCare by 7.7% in the 1st quarter. Azzad Asset Management Inc. ADV now owns 11,940 shares of the company’s stock worth $1,118,000 after buying an additional 852 shares during the last quarter. Integrated Advisors Network LLC bought a new position in Addus HomeCare during the 1st quarter valued at approximately $213,000. Finally, Moran Wealth Management LLC increased its position in Addus HomeCare by 10.5% during the 1st quarter. Moran Wealth Management LLC now owns 19,938 shares of the company’s stock valued at $1,867,000 after buying an additional 1,892 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ADUS has been the topic of several analyst reports. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. Barclays raised their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a report on Wednesday, July 8th. Finally, Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and an average price target of $131.50.

Read Our Latest Stock Report on Addus HomeCare

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the transaction, the insider owned 44,371 shares in the company, valued at approximately $4,160,668.67. This represents a 0.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 788 shares of company stock worth $73,506. 4.10% of the stock is currently owned by corporate insiders.

Addus HomeCare Stock Performance

Shares of ADUS opened at $111.40 on Thursday. The company has a market cap of $2.08 billion, a price-to-earnings ratio of 20.59, a P/E/G ratio of 1.55 and a beta of 0.88. The business’s fifty day simple moving average is $98.39 and its two-hundred day simple moving average is $101.12. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.52 by $0.10. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. During the same quarter in the previous year, the business earned $1.42 earnings per share. The company’s revenue was up 7.7% on a year-over-year basis. Research analysts anticipate that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

About Addus HomeCare

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Read More

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.